| Literature DB >> 35091813 |
Max Jochums1, Lars M H Reinders2, Jochen Tuerk2, Thorsten Teutenberg2.
Abstract
In order to ensure a high level of product quality and safety, regular quality controls are mandatory, especially in the pharmaceutical industry. These quality controls are strictly regulated and require a high level of documentation. With the goal of complete traceability, these regulations are constantly being tightened, while a majority of laboratories are working still completely paper-based. This leads to an ever-increasing workload that keeps laboratory staff away from value-adding analytical work. In order to realize complete traceability, a reduction in documentation errors and at the same time a reduction of the individual workload, the digitization of complete workflows seems to be a promising solution.Due to the ongoing shortage of IT specialists and the resulting high implementation costs, many laboratories are understandably hesitant. In this chapter an alternative is presented on how to approach the digitization of complete workflows without the need for IT specialists. The example of quality control analysis of cytotoxic drug solutions was chosen to demonstrate the challenges of such a digitization project. In this way, we contribute to a comprehensive understanding of the tools already available, which can also help other laboratories in their digitization efforts. At the end compliance with GMP and EN ISO/IEC 17025 (2017) regulations was reached.Entities:
Keywords: Cytostatic drugs; Digitization; FutureLab.NRW; Lab execution system (LES); Quality control (QC); Reporting
Mesh:
Substances:
Year: 2022 PMID: 35091813 DOI: 10.1007/10_2021_190
Source DB: PubMed Journal: Adv Biochem Eng Biotechnol ISSN: 0724-6145 Impact factor: 2.768